Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 31, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Characterizing clinically significant prostate cancer using template prostate mapping biopsy.

Hashim Uddin Ahmed1, Yipeng Hu, Tim Carter

  • 1Division of Surgery and Interventional Science, Centre for Medical Imaging Computing, University College London, Department of Histopathology, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom. hashim.ahmed@ucl.ac.uk

The Journal of Urology
|June 18, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported health and quality of life after midurethral sling: a comparative analysis from VIGI-MESH registry.

The French journal of urology·2026
Same author

Clinical Validation of the Roche cobas and cobas 4800 Human Papillomavirus Tests on Self-Collected Vaginal Dry Swabs versus Practitioner-Collected Cervical Specimens Using the VALHUDES Protocol.

The Journal of molecular diagnostics : JMD·2026
Same author

Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials.

European urology oncology·2026
Same author

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing.

British journal of cancer·2026
Same author

PromptReg: Interactive Registration by "Corresponding Prompts" for Segment Anything Model (SAM).

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trial.

Contemporary clinical trials·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Uro-Science.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
See all related articles

Transperineal prostate mapping biopsy offers improved risk stratification for prostate cancer. New definitions combining Gleason grade and cancer burden accurately identify clinically significant disease, requiring further validation.

Area of Science:

  • Urology
  • Oncology
  • Medical Imaging

Background:

  • Transrectal ultrasound guided biopsy has limitations in accurately assessing prostate cancer grade and burden due to errors.
  • Accurate prostate cancer risk stratification is crucial for effective treatment planning.
  • Transperineal prostate mapping biopsy presents a potential alternative for improved accuracy.

Purpose of the Study:

  • To define the characteristics of transperineal prostate mapping biopsy for clinically significant prostate cancer.
  • To evaluate the accuracy of transperineal prostate mapping biopsy in detecting various cancer lesion sizes.
  • To develop new definitions for clinically significant prostate cancer based on biopsy findings.

Main Methods:

  • Reconstruction of 3D models from 107 radical whole mount prostatectomy specimens.

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Related Experiment Videos

Last Updated: May 31, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

  • Simulation of 500 transperineal prostate mapping biopsies per case, varying needle targeting errors.
  • Calculation of sensitivity, specificity, and predictive values for detecting lesions ≥0.2 ml or ≥0.5 ml.

    • Main Results:

    • Derived cancer burden thresholds: total core length ≥10 mm (≥0.5 ml) or ≥6 mm (≥0.2 ml), and maximum core length ≥6 mm (≥0.5 ml) or ≥4 mm (≥0.2 ml) to detect >95% of lesions.
    • Combined these thresholds with Gleason pattern 4 to create two definitions of clinically significant disease.
    • Mean patient age 61 years, mean PSA 9.7 ng/ml.

    Conclusions:

    • Transperineal prostate mapping biopsy shows promise for risk stratification in localized prostate cancer.
    • The developed definitions for clinically significant disease require prospective validation.
    • This technique may enhance the accuracy of prostate cancer assessment.